Drug improves survival in metastatic breast cancer
Thursday, October 25, 2018 - 13:30
in Health & Medicine
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.